CRL Chief Scientific Officer Dr. Robert Stout discusses the lasting impact of COVID-19 infection in both symptomatic and asymptomatic patients…. Read More
Welcome to the CRL Insurer Services blog. From big data and insurtech to accelerated underwriting and self-service products, the world of life insurance is moving at an unprecedented pace. We are confident that mortality data and insurance industry capabilities will continue to evolve, and seek to provide relevant expertise and updates to our valued clients.
As we continue to provide lab, data, and underwriting services through the CRL Insurers Business Unit, we look forward to sharing updates with you here. Check out the latest posts below from our dedicated team of medical directors and industry leaders, who provide commentary on timely topics, innovative services and solutions, and the existing database of CRL expertise.
Dr. Steven J. Rigatti explores marijuana use during the COVID-19 pandemic as a follow-up to earlier commentary on alcohol and tobacco use…. Read More
Delta-8 Compound Marijuana testing is used by a number of life insurers in the risk assessment process. New chemical entities… Read More
See below for details on the latest CRL acquisition. We are pleased to share that CRL has acquired Confirm BioSciences, a… Read More
Learn about our electronic lab slip products including eSlip and SecureSlip, and why you should implement digital workflow automation today. … Read More
As COVID-19 continues to be top of mind, we are committed to serving our customers and understanding the virus. There… Read More
Epigenetic testing is a critical part of CRL’s approach to innovative science. Read below to learn about how epigenetic testing… Read More